Bookmark

Add to MyYahoo RSS

Rigel Pharmaceuticals News

News on Rigel Pharmaceuticals (Ticker: RIGL) continually updated from thousands of sources around the net.

Wednesday Aug 13 | TheStreet.com

Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Startups, Mozilla, Warren Buffett

Wednesday Aug 13 | BioSpace

Rigel Pharmaceuticals, Inc. Experimental Eye Drug R348 Fails Mid-Stage Study

The endpoints were measured by changes in corneal fluorescein staining, conjunctival staining, tear production and dry eye symptom scores from baseline over 12 weeks of treatment versus placebo.

Comment?

Related Topix: Startups

Wednesday Aug 13 | Reuters

UPDATE 1-Rigel experimental eye drug fails mid-stage study

Rigel Pharmaceuticals Inc said its experimental drug failed to meet the main goal in a mid-stage study in patients with dry eye disease, sending its shares down 10.7 percent in premarket trading.

Comment?

Related Topix: Startups, San Francisco County, CA, San Francisco, CA

Tue Aug 05, 2014

BioSpace

Rigel Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results

Weighted average shares outstanding for the second quarters of 2014 and 2013 were 87.5 million and 87.1 million, respectively.

Comment?

Related Topix: Startups

Wed Jul 16, 2014

Applied Clinical Trials

Rigel Initiates Phase 3 Studies of Fostamatinib in ITP

The focus of these clinical studies is to evaluate the potential of fostamatinib to increase the platelet counts of patients with chronic ITP.

Comment?

Related Topix: Startups, Platelet Count, Health

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••